By Marcia Dunn
NASA held its first public meeting on UFOs Wednesday a year after launching a study into unexplained sightings.
The space agency televised the hourslong hearing featuring an independent panel of experts. The team includes 16 scientists and other experts selected by NASA including retired astronaut Scott Kelly, the first American to spend nearly a year in space.
Several committee members have been subjected to “online abuse” for serving on the team, which detracts from the scientific process, said NASA's Dan Evans, adding that NASA security is dealing with it.
“It’s precisely this rigorous, evidence-based approach that allows one to separate the fact from fiction," Evans said.
The study is a first step in trying to explain mysterious sightings in the sky that NASA calls UAPs, or unidentified aerial phenomena.
The group is looking at what unclassified information is available on the subject and how much more is needed to understand what's going on in the sky, according to astrophysicist David Spergel, the committee's chair who runs the Simons Foundation.
No secret military data are included, such as anything surrounding the suspected spy balloons from China spotted flying over the U.S. earlier this year.
The meeting was held at at NASA headquarters in Washington with the public taking part remotely.
A final report is expected by the end of July.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
The sophisticated rocket sent a payload that included 24 satellites, a new, solar-powered space sail, and the ashes of 152 people, into space with its side boosters successfully returning to Earth unscathed.
That next step for meat alternatives will apparently include fish as companies like Wild Type, BlueNalu, and Finless Foods wager that, in the age of plant-based burgers, there’s room for seafood grown in the lab.
These are the headlines you Need 2 Know for Wednesday, June 19, 2019.
Elon Musk may be going to Vegas. The Las Vegas Convention and Visitors Authority has recommended that The Boring Company be chosen to construct a "people mover" below the expanding convention center.
Cannabis, hemp, reefer, marijuana, dope, pot, grass ー no matter what term you choose, they all refer to the same plant: cannabis sativa. It’s a common misconception that cannabis sativa exclusively means that particular strain of weed that makes you creative and focused (as opposed to indica, which promotes relaxation)ー but it’s actually the scientific name of the single plant that yields marijuana, CBD, and hemp, among other products.
These are the headlines you Need 2 Know for Tuesday, Feb. 19, 2019.
Canopy Growth CEO Bruce Linton won't guarantee investors dividends. What he will promise is a stake in global cannabis domination. "If people want a dividend, we are probably not the right stock. If they want some entity aimed at dominating a global opportunity that started in Canada, we are probably your best bet," Linton told Cheddar on Friday, one day after the company reported a massive spike in third-quarter revenue.
These are the headlines you Need 2 Know for Friday, Feb, 15, 2019.
It's a big week in cannabis earnings ー Aurora Cannabis reported Monday and Canopy Growth will report Thursday ー but Paul Rosen, CEO of cannabis private equity firm Tidal Royalty, said he's noticing a concerning trend."All the companies are facing gross margin compression because there are excise taxes, there's a massive marketing spend as we go to recreational cannabis, and there's also increased packaging costs. So I think you're going to see a trend line here, which is revenue and capacity going up, but gross margin is going down," Rosen told Cheddar Wednesday.
Opiant Pharmaceuticals, the developer of opioid antidote NARCAN, is in the process of developing a version of its lifesaving drug for cannabanoid overdoses, the company's CEO told Cheddar in an interview on Wednesday.
